Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609).
Xu LiangAdrien BriauxVéronique BecetteCamille BenoistAnais BoulaiWalid ChemlaliAnne SchnitzlerSylvain BaulandeSofia RiveraMarie-Ange Mouret-ReynierLaurence Venat BouvetThibaut De La Motte RougeJérôme LemonnierFlorence LereboursCéline CallensPublished in: Journal of hematology & oncology (2018)
This trial is registered with ClinicalTrials.gov ( NCT00629616 ) on March 6, 2008, retrospectively registered.